Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/9/2018
SIETES contiene 92557 citas

 
 
 1 a 20 de 5768 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
El Zahran T, Schier J, Glidden E, Kieszak S, Law R, Bottei E, Aaron C, King A, Chang A. Characteristics of tianeptine exposures reported to the National Poison Data System — United States, 2000–2017. Morbidity and Mortality Weekly Report 2018;67:3 de agosto. [Ref.ID 102752]
2.Tiene citas relacionadas Cita con resumen
Thielking M. Poison control calls spike for unapproved drug that produces opioid-like highs. STAT Daily Recap 2018:2 de agosto. [Ref.ID 102737]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ 2018;361:23 de mayo. [Ref.ID 102648]
6.Enlace a cita original Cita con resumen
Maxwell CJ, Campitelli MA, Hogan DB, Diong C, Austin PC, Amuah JE, Lapane K, Seitz DP, Gill SS, Gruneir A, Wodchis WP, Bronskill SE. Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition. Pharmacoepidemiol Drug Saf 2018;27:marzo. [Ref.ID 102632]
7. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
8. Cita con resumen
Darrow JJ, Avorn J, Kesselheim AS. The FDA breakthrough-drug designation - Four years of experience. N Engl J Med 2018;378:16 de abril. [Ref.ID 102515]
9.Enlace a cita original Cita con resumen
Montastruc F, Bénard-Laribière A, Noize P, Pambrun E, Diaz-Bazin F, Tournier M, Bégaud B, Pariente A. Antipsychotics use: 2006–2013 trends in prevalence and incidence and characterization of users. Eur J Clin Pharmacol 2018;74:mayo. [Ref.ID 102512]
10.Enlace a cita originalTiene citas relacionadas Cita con resumen
Cipriani A, Furukwa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. . Lancet 2018;391:7 de abril. [Ref.ID 102476]
11.Enlace a cita original Cita con resumen
Huybrechts KF, Bröms G, Christensen LB, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernández-Díaz S, Karlsson P, Karlstad Ø, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Sørensen HT, Zoega H, Bateman BT. Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy safety study consortium. JAMA Psychiatry 2017:13 de diciembre. [Ref.ID 102188]
12. Cita con resumen
Burcu M, Zito JM, Safer DJ, Magder LS, dos-Reis S, Shaya FT, Rosenthal GL. Association of antidepressant medications with incident type 2 diabetes among Medicaid-insured youths. JAMA Pediatrics 2017:16 de octubre. [Ref.ID 102122]
13. Cita con resumen
Brett J, Daniels B, Karanges EA, Buckley NA, Schneider C, Nassir A, McLachlan AJ, Pearson S-A. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. Br J Clin Pharmacol 2017;83:2581-8. [Ref.ID 102118]
14. Cita con resumen
Gao S-Y, Wu Q-J, Zhang T-N, Shen Z-Q, Liu C-X, Xu X, Ji C, Zhao Y-H. Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies. Br J Clin Pharmacol 2017;83:2134. [Ref.ID 102080]
15. Cita con resumen
Alshehri GH, Keers RN, Ashcroft DM. Frequency and nature of medication errors and adverse drug events in mental health hospitals: a systematic review. Drug Saf 2017;40:871-86. [Ref.ID 102076]
16. Cita con resumen
Morkem R, Williamson T, Patten S, Queenan JA, Wong ST, Manca D, Barber D. Trends in antidepressant prescribing to children and adolescents in Canadian primary care: A time-series analysis. Pharmacoepidemiol Drug Saf 2017;26:1093-9. [Ref.ID 102065]
17. Cita con resumen
Herr M, Sirven N, Grondin H, Pichetti S, Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol 2017;73:1165-72. [Ref.ID 102024]
18. Cita con resumen
Ramaekers JG. Drugs and driving research in medicinal drug development. Trends Pharmacol Sci 2017;38:319-21. [Ref.ID 101986]
19. Cita con resumen
Waade RB, Molden E, Martinsen MI, Hermann M, Ranhoff AH. Psychotropics and weak opioid analgesics in plasma samples of older hip fracture patients – Detection frequencies and consistency with drug records. Br J Clin Pharmacol 2017;83:1397-404. [Ref.ID 101985]
20. Cita con resumen
Rai D, Lee BK, Dalman C, Newschaffer C, Lewis G, Magnusson C. Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017;358:j2811. [Ref.ID 101979]
Seleccionar todas
 
 1 a 20 de 5768 siguiente >>